TABLE 2.

Diagnoses, Glucose-Influencing Medical Therapy, and Mortality

Diagnosis	Frequency, n (% of Total Cohort)	Glucose-Influencing Therapy, n (% of Diagnostic Group)	Disease-Specific Mortality, n (% of Diagnostic Group)
Respiratory illness	35 (49)	31 (89)	2 (6)
Asthma	22 (31)	22 (100)	1 (5)
Pneumonia	5 (7)	3 (60)	1 (20)
Bronchiolitis	1 (1)	1 (100)	0 (0)
Other respiratory illness	7 (10)	5 (71)	0 (0)
Cardiovascular	4 (5)	4 (100)	4 (100)
Gastrointestinal	3 (4)	1 (33)	1 (33)
Dehydration	2 (3)	1 (50)	0
Infectious	3 (4)	2 (67)	0
Oncologic	2 (3)	2 (100)	0
Neurologic	7 (10)	2 (29)	3 (43)
Seizure	5 (7)	1 (20)	1 (20)
Other neurologic illness	2 (3)	1 (50)	1 (50)
Trauma	12 (17)	3 (25)	6 (50)
Toxic exposure	4 (5)	1 (25)	0 (0)
Total	72 (100)	47 (65)	16 (22)